M&A: To Deal or Not to Deal

Authored by Jacob Ambrose Willson, Senior Editor, Criticaleye

In a capital constrained environment, some might argue that now is not the time for businesses to be pursuing growth via M&A. Others might posit that the best deals are struck at weak points in the economic cycle. Senior Editor Jacob Ambrose Willson asks Criticaleye Members for their views on executing M&A in 2023 and beyond.

Featuring Commentary From:

Michel Driessen, Senior Partner, Strategy and Transactions, EY
Alastair Mills, Managing Director & Head of European Business Services, H.I.G. Capital
Michael Teixeira, CEO, MVF
Helen Wiseman, Chair, Elixinol Wellness

Share this with your Community



Contributors
Alastair Mills
Managing Director & Head of European Business Services
H.I.G. European Capital Partners LLP
Helen Wiseman
NED & Audit Committee Chair
Bid Corporation
Michael Teixeira
CEO
MVF
Michel Driessen
Partner - Markets Leader UKI, Transaction Advisory Services
EY, More London Place


Click here to download this insight

DOWNLOAD INSIGHT



Related Insights

Read, watch & listen to some of the latest thought leadership from our Community.


Mike Maudsley, CEO of enfinium: How Great CEOs Stay Ahead of the Curve

Mike Maudsley, CEO of enfinium, joins Bridgette Hall, Senior Editor at Criticaleye, to explore what it takes to succeed as a CEO in today’s fast-changing business environment. As organisations navigate incr...


Click here to download this insight

Employee Happiness in the Age of AI

In this report, AlixPartners and Darwin X argue that retail consistently trails other industries on employee happiness, and that closing that gap is not just a people issue, but a prerequisite for competing in the ag...


The Future of Executive Leadership and High Performance

Andrew Darfoor, SID, Post Office & Board Mentor at Criticaleye, and Jodene Young, Chief People Officer at the National Physical Laboratory (NPL), join Bridgette Hall, Senior Editor at Criticaleye, for a discussio...


1 2 3 4 5 6 7 8 9 10
Displaying 1 to 3 of 184




GlaxoSmithKline plc London Stock Exchange Group Rolls-Royce LACE Partners Stream NatWest Group CrowdStrike Southern Water Aldermore Group Global Payments Legal & General Mayborn Group Lightsource bp NATS Drax Group plc Canaccord Genuity Group Inc British Land AlixPartners Hitachi Solutions E.ON UK